99 related articles for article (PubMed ID: 20972906)
21. Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor.
Hsu KH; Yang TM; Shan YS; Lin PW
Am J Surg; 2007 Aug; 194(2):148-52. PubMed ID: 17618793
[TBL] [Abstract][Full Text] [Related]
22. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour.
Hohenberger P; Ronellenfitsch U; Oladeji O; Pink D; Ströbel P; Wardelmann E; Reichardt P
Br J Surg; 2010 Dec; 97(12):1854-9. PubMed ID: 20730857
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours.
Aparicio T; Boige V; Sabourin JC; Crenn P; Ducreux M; Le Cesne A; Bonvalot S
Eur J Surg Oncol; 2004 Dec; 30(10):1098-103. PubMed ID: 15522557
[TBL] [Abstract][Full Text] [Related]
24. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal stromal tumors (GISTs): analysis of 20 cases.
Bölükbasi H; Nazli O; Tansug T; Bozdag AD; Isgiider AS; Yaman I; Haciyanli M; Genc H
Hepatogastroenterology; 2006; 53(69):385-8. PubMed ID: 16795978
[TBL] [Abstract][Full Text] [Related]
26. KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutants.
Lasota J; Kuban W; Wardelmann E; Debiec-Rychter M; Merkelbach-Bruse S; Sciot R; Rys J; Steigen SE; Iwanik K; Holden JA; Jerzak Vel Dobosz A; Schildhaus HU; Miettinen M
Hum Pathol; 2008 Dec; 39(12):1728-36. PubMed ID: 18715619
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of gastric stromal tumors.
Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal stromal tumors: pathogenesis and current treatment.
Arru JM; Richardson JD
J Ky Med Assoc; 2005 May; 103(5):211-5. PubMed ID: 15918651
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal stromal tumors: a 7-year experience from a tertiary care hospital.
Lakshmi VA; Chacko RT; Kurian S
Indian J Pathol Microbiol; 2010; 53(4):628-33. PubMed ID: 21045382
[TBL] [Abstract][Full Text] [Related]
30. [Gastrointestinal stromal tumor: epidemiology and outcome study in 40 cases].
Bellil K; Haouet S; Bellil-Ben Haha S; Jouini M; Bouraoui S; Boubaker J; Boussen H; Kchir N; Zitouna K
Tunis Med; 2006 Jan; 84(1):26-9. PubMed ID: 16634209
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal stromal tumors: actin expression, a new prognostic factor?
Ruiz-Tovar J; Diez-Tabernilla M; Housari G; Martinez-Molina E; Sanjuanbenito A
Am Surg; 2010 Nov; 76(11):1244-50. PubMed ID: 21140693
[TBL] [Abstract][Full Text] [Related]
32. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
[TBL] [Abstract][Full Text] [Related]
33. [Gastrointestinal stromal tumours: clinical and therapeutic features. A report of 25 cases].
Bdioui H; Jouini M; Bouzaiene H; Nouira K; Fteriche F; Ksantini R; Chebbi F; Kacem MJ; Ben Safta Z
Tunis Med; 2006 Oct; 84(10):599-602. PubMed ID: 17193848
[TBL] [Abstract][Full Text] [Related]
34. Recurrent GI bleeding and surgery following the initial response to imatinib therapy in GIST of the stomach.
El Hajj II; Chehal A; El Saghir NS
Dig Dis Sci; 2005 Jan; 50(1):65-9. PubMed ID: 15712639
[No Abstract] [Full Text] [Related]
35. [Clinical analysis of prognostic factors for patients with gastrointestinal stromal tumors].
Jie ZG; Xie XP; Qin KW; Liu Y; Li ZR; Dai AB; Yao YX
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):210-2. PubMed ID: 16167229
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of gastrointestinal stromal tumors of the stomach: report of 28 cases.
Wu Y; Zhu X; Ding Y
Ann Clin Lab Sci; 2007; 37(1):15-21. PubMed ID: 17311865
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic features and prognostic factors of gastric gastrointestinal stromal tumor with synchronous gastric cancer].
Liu XL; Wang JB; Huang CM; Zheng CH; Li P; Xie JW; Lin JX
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):247-50. PubMed ID: 22454170
[TBL] [Abstract][Full Text] [Related]
38. Synchronous gastrointestinal stromal tumors (GIST) and other primary cancers: case series of a single institution experience.
Ferreira SS; Werutsky G; Toneto MG; Alves JM; Piantá CD; Breunig RC; Brondani da Rocha A; Grivicich I; Garicochea B
Int J Surg; 2010; 8(4):314-7. PubMed ID: 20380900
[TBL] [Abstract][Full Text] [Related]
39. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of prognostic and clinicopathologic factors in gastrointestinal stromal tumors of the stomach].
Bai YK; Shao YF; Cao WL; Shi SS; Yu LW
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):21-5. PubMed ID: 17253167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
